LegoChem Bioscience said it signed an antibody-drug conjugate (ADC) joint research and development agreement with NextCure, a U.S. pharmaceutical company.Under the accord, the two companies plan to discover new ADC anticancer drugs by utilizing Next Cure's B7-H4 antibody and LegoChem's ADC platform
Lunit, a company specializing in medical artificial intelligence (AI) solutions, said on Wednesday that it acquired the operating rights in a bid for the Breast Screening New South Wales (BSNSW) state program in Australia.BSNSW is an Australian state-run program that provides free breast cancer scre
Roche Korea’s Tecentriq (atezolizumab) has expanded its indication to postoperative adjuvant therapy for the first time among lung cancer immunotherapies but fell short of expectations, industry watchers said on Wednesday.Last Friday, the Ministry of Food and Drug Safety approved the use of Tecentri
Humasis, an in vitro diagnosis kit maker, saw its sales drop sharply in the third quarter.According to industry watchers on Wednesday, the conflict between the company and its minority shareholders has also expanded to a management dispute, deepening worries about corporate competitiveness.Humasis u
President Yoon Suk-yeol pledged Korea's active contribution to strengthening international health solidarity during a session focusing on health at the G20 Indonesia Summit."The preciousness of freedom and the importance of solidarity were reminded once again at a time when the global community is r
Macrogen, a Korean genome analysis company, held a groundbreaking ceremony on Tuesday to commence construction of the “nation's largest” genome foundry, Macrogen Sejong Campus, in Sejong City for innovation in genome analysis.Macrogen Chairman Seo Jung-sun and Global Business CEO Lee Su-kang were am
Researchers at the Catholic University of Korea said they discovered a novel cytokine immune protein, p40, and EB13, that can control immune T cells for the treatment of intractable autoimmune diseases like rheumatoid arthritis.The interleukin (IL)-12 cytokine family is associated with T cells that
Lance Little, head of Roche Diagnostics Asia Pacific, said the diagnostics industry should put priority on providing patient-centric services at an online conference on Tuesday.The company hosted the conference under the theme, “Partnering patients to revolutionize care in the Asia Pacific” involvin
As advances in medical technology identify one genetic mutation after another in lung cancer, the early diagnosis of rare lung cancer and the development of targeted treatments are progressing.Regulators recently approved Rybrevant (amivantamab) as the target treatment for EGFR (Epidermal Growth Fac
Middle Eastern countries including such as the United Arab Emirates (UAE) and Saudi Arabia are becoming major importers of Korean biopharmaceutical products.According to the Korea Customs Service's import and export statistics on Tuesday, exports of medical supplies, including pharmaceuticals and di
Korea's new Covid-19 tally bounced back to above 70,000 for the first time in two months on Tuesday.According to the Korea Disease Control and Prevention Agency (KDCA), Korea added 72,883 new Covid-19 infections, including 50 cases from abroad, bringing the total caseload to 26,290,877.The figure on
United Pharm is about to apply for the regulatory approval of a combo therapy, which combines the antithrombotic ingredient of cilostazol with the dyslipidemia component of rosuvastatin.Industry insiders pay attention to whether Korea United Pharm, which emerged as a significant player in the antith
The government said it would look into whether state-funded developers of Covid-19 vaccines and treatments made any attempts to exaggerate clinical development status or inflate their stock prices. The evaluation, consisting of a team of external experts, will start in January next year after the Ko
AptaBio, a developer of innovative drugs for intractable diseases, said on Tuesday that it will present the treatment effect of APX-NEW, an oxidative stress drug for the treatment of Parkinson's disease, at the Society for Neuroscience (SFN) on Nov.12-16 in San Diego, the U.S.APX-NEW is a drug with
Is it necessary for biopharmaceutical companies to introduce the “ESG (environment, society, and governance) management,” which has emerged as a new corporate keyword for businesses worldwide?If so, how should biopharma firms prepare for “ESG management?”What “ESG management” strategies are global b
Dx&Vx, a Korean molecular diagnostics company, said Wednesday that it recorded 8.6 billion won ($ 6.4 million) in sales in the third quarter, up 82.8 percent from the same period in 2021.The company also registered 412.2 million and 620.8 million won in operating and net profit, down 56.5 and 67.8 p
The Korea Health Industry Development Institute (KHIDI) said on Tuesday that a delegation from Abu Dhabi’s Department of Health International Patient Care Center (DOH IPCC) visited six hospitals in Korea to gauge how much Emiratis patients were satisfied with Korean hospital services. They also disc
Jung Ki-seok, a top adviser to the government's COVID-19 task force, said on Monday that the government was concerned about the low Covid-19 booster vaccination rate during the winter season ahead of the full-fledged Covid-19 recurrence."Summer and winter are different as winter poses extra risks of
Hanmi Science, which recently merged with affiliate Hanmi Healthcare, said it will strengthen its medical device business, including surgical materials.Hanmi Science, a holding company of Hanmi Group, decided to merge with its affiliates, Hanmi Healthcare, in September and completed the merger proce
Some Korean biopharmaceutical companies have benefited from local currency weakening against the dollar in the second half, mainly due to their large proportions of exports, while importers of drug ingredients suffered headwinds.The Korean won has been sliding against the greenback throughout 2022.